Literature DB >> 11176739

Screening and intervention for illicit drug abuse: a national survey of primary care physicians and psychiatrists.

P D Friedmann1, D McCullough, R Saitz.   

Abstract

BACKGROUND: Illicit drug abuse causes much morbidity and mortality, yet little is known about physicians' screening and intervention practices regarding illicit drug abuse.
METHODS: We mailed a survey to a national sample of 2000 practicing general internists, family physicians, obstetricians and gynecologists, and psychiatrists to assess their screening and intervention practices for illicit drug abuse.
RESULTS: Of 1082 respondents (adjusted response rate, 57%), 68% reported that they regularly ask new outpatients about drug use. For diagnosed illicit drug abuse, 55% reported that they routinely offer formal treatment referral, but 15% reported that they do not intervene. In multivariate logistic regression models, more optimal screening and intervention practices were associated with psychiatry specialty, confidence in obtaining the history of drug use, optimism about the effectiveness of therapy, less concern that patients will object, and fewer perceived time constraints.
CONCLUSIONS: Most physicians reported that they ask patients about illicit drug use, but a substantial minority inadequately intervene in diagnosed drug abuse. Initiatives to promote physician involvement in illicit drug abuse should include strategies to increase physicians' confidence in managing drug problems, engender optimism about the benefits of treatment, dispel concerns about patients' sensitivity regarding substance use, and address perceived time limitations.

Entities:  

Mesh:

Year:  2001        PMID: 11176739     DOI: 10.1001/archinte.161.2.248

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  34 in total

Review 1.  Evidence-based practices for substance use disorders.

Authors:  Mark P McGovern; Kathleen M Carroll
Journal:  Psychiatr Clin North Am       Date:  2003-12

2.  Improving temporal efficiency of outpatient buprenorphine induction.

Authors:  Erik W Gunderson; Frances R Levin; Margaret M Rombone; Suzanne K Vosburg; Herbert D Kleber
Journal:  Am J Addict       Date:  2011-07-18

3.  Impact of a brief training on medical resident screening for alcohol misuse and illicit drug use.

Authors:  Erik W Gunderson; Frances R Levin; Patricia Owen
Journal:  Am J Addict       Date:  2008 Mar-Apr

Review 4.  Training physicians to treat substance use disorders.

Authors:  Soteri Polydorou; Erik W Gunderson; Frances R Levin
Journal:  Curr Psychiatry Rep       Date:  2008-10       Impact factor: 5.285

5.  Recreational drug use among primary care patients: implications of a positive self-report.

Authors:  Judith Bernstein; Debbie M Cheng; Na Wang; Caitlin Trilla; Jeffrey Samet; Richard Saitz
Journal:  Ann Fam Med       Date:  2015 May-Jun       Impact factor: 5.166

6.  Negotiating substance use stigma: the role of cultural health capital in provider-patient interactions.

Authors:  Jamie Chang; Leslie Dubbin; Janet Shim
Journal:  Sociol Health Illn       Date:  2015-09-18

7.  Electronic Health Record-Based Screening for Substance Abuse.

Authors:  Farrokh Alemi; Sanja Avramovic; Mark D Schwartz
Journal:  Big Data       Date:  2018-09-19       Impact factor: 2.128

8.  Assessing Problematic Substance Use in HIV Care: Which Questions Elicit Accurate Patient Disclosures?

Authors:  Wynne Callon; Mary Catherine Beach; Somnath Saha; Geetanjali Chander; Ira B Wilson; Michael Barton Laws; Victoria Sharp; Jonathan Cohn; Richard Moore; P Todd Korthuis
Journal:  J Gen Intern Med       Date:  2016-05-19       Impact factor: 5.128

9.  Feasibility and acceptability of an audio computer-assisted self-interview version of the Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) in primary care patients.

Authors:  Suzanne E Spear; Michele Shedlin; Brian Gilberti; Maya Fiellin; Jennifer McNeely
Journal:  Subst Abus       Date:  2016 Apr-Jun       Impact factor: 3.716

10.  A national physician survey on prescribing syringes as an HIV prevention measure.

Authors:  G E Macalino; D Dhawan Sachdev; J D Rich; C Becker; L J Tan; L Beletsky; S Burris
Journal:  Subst Abuse Treat Prev Policy       Date:  2009-06-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.